Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
The Division of Laboratory Diagnostic Analysis of the Capital Regional Center for Disease Control and Prevention conducted variant analysis on SARS-CoV-2-positive samples from the National Incheon Airport Quarantine Station, National Incheon Quarantine Station, and private diagnostic testing centers at Incheon International Airport from February 15, 2021, to March 2023. In total, 13,098 samples from COVID-19 cases from 130 countries were analyzed using the Genomic Surveillance project in the Republic of Korea. They included 12,364 cases (94.4%) of the Omicron family; 658 cases of Delta (5.0%); 55 cases of Alpha (0.4%); 5 cases of Beta; 4 cases of Epsilon; 3 cases each of Gamma, Kappa, and Iota; 2 cases of Eta; and 1 case of Theta SARS-CoV-2 variants. The countries with the highest number of imported cases were Indonesia in 2021 (222 cases, 28.0%), the United States in 2022 (1,942 cases, 17.1%), and China from January to March 2023 (345 cases, 37.3%).Most variants of concern in the Republic of Korea were introduced from various countries. As the importation of recombinant variants generated among sublineages of the Omicron variant increases in 2023, there is an increasing need for genomic analysis through whole-genome sequencing of SARS-CoV-2 variants to enable more accurate classification. Capital Regional Center for Disease Control and Prevention plans to continue to conduct SARS-CoV-2 variant analysis based on a 24-hour diagnostic testing system to effectively monitor the imported cases infectious diseases from abroad and take efficient domestic quarantine measures.
The Division of Laboratory Diagnostic Analysis of the Capital Regional Center for Disease Control and Prevention conducted variant analysis on SARS-CoV-2-positive samples from the National Incheon Airport Quarantine Station, National Incheon Quarantine Station, and private diagnostic testing centers at Incheon International Airport from February 15, 2021, to March 2023. In total, 13,098 samples from COVID-19 cases from 130 countries were analyzed using the Genomic Surveillance project in the Republic of Korea. They included 12,364 cases (94.4%) of the Omicron family; 658 cases of Delta (5.0%); 55 cases of Alpha (0.4%); 5 cases of Beta; 4 cases of Epsilon; 3 cases each of Gamma, Kappa, and Iota; 2 cases of Eta; and 1 case of Theta SARS-CoV-2 variants. The countries with the highest number of imported cases were Indonesia in 2021 (222 cases, 28.0%), the United States in 2022 (1,942 cases, 17.1%), and China from January to March 2023 (345 cases, 37.3%).Most variants of concern in the Republic of Korea were introduced from various countries. As the importation of recombinant variants generated among sublineages of the Omicron variant increases in 2023, there is an increasing need for genomic analysis through whole-genome sequencing of SARS-CoV-2 variants to enable more accurate classification. Capital Regional Center for Disease Control and Prevention plans to continue to conduct SARS-CoV-2 variant analysis based on a 24-hour diagnostic testing system to effectively monitor the imported cases infectious diseases from abroad and take efficient domestic quarantine measures.
No abstract
The Korea Disease Control and Prevention Agency (KDCA) is conducting variant analysis through whole genome analysis to strengthen quarantine measures for confirmed cases of coronavirus disease 2019 arriving from China, as the number of confirmed cases in China has increased since December 2022. The BA.5 subvariants, which include BA.5 and BF.7, have been identified in >90% of confirmed cases of Chinese origin by Korea Respiratory Virus Integrated Surveillance System.An examination of Chinese-origin genetic data shared by China and other countries in the Global Initiative for Sharing All Influenza Data confirms similar findings, indicating that BA.5 subvariants, including BA.5 and BF.7, are currently predominant in China, accounting for >90% of cases. To date, no variants of significant concern have been identified. However, as the number of confirmed cases in China rises, the KDCA will continue to conduct enhanced mutation surveillance to detect the introduction and/or domestic emergence of new variants. In addition, the KDCA will strengthen international cooperation by actively sharing relevant information.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.